BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19451253)

  • 21. Lifestyle modification in management of diabetes mellitus.
    Sahay BK; Sahay RK
    J Indian Med Assoc; 2002 Mar; 100(3):178-80. PubMed ID: 12408279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
    Klein S; Burke LE; Bray GA; Blair S; Allison DB; Pi-Sunyer X; Hong Y; Eckel RH;
    Circulation; 2004 Nov; 110(18):2952-67. PubMed ID: 15509809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.
    Smith SC; Blair SN; Bonow RO; Brass LM; Cerqueira MD; Dracup K; Fuster V; Gotto A; Grundy SM; Miller NH; Jacobs A; Jones D; Krauss RM; Mosca L; Ockene I; Pasternak RC; Pearson T; Pfeffer MA; Starke RD; Taubert KA
    J Am Coll Cardiol; 2001 Nov; 38(5):1581-3. PubMed ID: 11691544
    [No Abstract]   [Full Text] [Related]  

  • 24. [Management of diabetes in cardiac diseases].
    Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metabolic syndrome and cardiovascular disease: part 2.
    Jiamsripong P; Mookadam M; Alharthi MS; Khandheria BK; Mookadam F
    Prev Cardiol; 2008; 11(4):223-9. PubMed ID: 19476575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW; Jaff MR
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of the metabolic syndrome: the new epidemic.
    Sorrentino MJ
    Am J Cardiol; 2005 Aug; 96(4A):3E-7E. PubMed ID: 16098835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The challenge of risk reduction therapy for cardiovascular disease.
    Smith SC
    Am Fam Physician; 1997 Feb; 55(2):491-500. PubMed ID: 9054219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intervention in risk factors and protection of target organs].
    Gascón Ramón G; Bertomeu i Blanch F; Baño Aracil M; Madrigal JA
    An Med Interna; 1997 Sep; 14(9):478-84. PubMed ID: 9453760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
    Carević V; Rumboldt M; Rumboldt Z;
    Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity, hyperlipidemia, and metabolic syndrome.
    Charlton M
    Liver Transpl; 2009 Nov; 15 Suppl 2():S83-9. PubMed ID: 19877024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
    Suzuki T; Homma S
    Med Clin North Am; 2007 Nov; 91(6):1211-23, x. PubMed ID: 17964917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of the metabolic syndrome in obesity.
    Liberopoulos EN; Mikhailidis DP; Elisaf MS
    Obes Rev; 2005 Nov; 6(4):283-96. PubMed ID: 16246214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early intervention and prevention of myocardial infarction.
    Pais PS
    J Hypertens Suppl; 2006 Apr; 24(2):S25-30. PubMed ID: 16601557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.
    Yusuf S; Hawken S; Ounpuu S; Dans T; Avezum A; Lanas F; McQueen M; Budaj A; Pais P; Varigos J; Lisheng L;
    Lancet; 2004 Sep 11-17; 364(9438):937-52. PubMed ID: 15364185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic options for treatment of cardiometabolic risk].
    Stokić E; Tomić-Naglić D; Derić M; Jorga J
    Med Pregl; 2009; 62 Suppl 3():54-8. PubMed ID: 19702117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Urolithiasis: a warning not to ignore].
    Raynal G; Daudon M; Traxer O
    Prog Urol; 2011 Dec; 21(13):965-6. PubMed ID: 22118363
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk factors in myocardial infarction.
    Can Med Assoc J; 1975 Nov; 113(10):917. PubMed ID: 1192303
    [No Abstract]   [Full Text] [Related]  

  • 39. Stroke prevention: modifying risk factors.
    Romero JR; Morris J; Pikula A
    Ther Adv Cardiovasc Dis; 2008 Aug; 2(4):287-303. PubMed ID: 19124428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment after myocardial infarction.
    Aronow WS
    Compr Ther; 2007; 33(1):39-47. PubMed ID: 17984493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.